Sati Pharma Limited - Due diligence report
A 360° intelligence report on Sati Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress si…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Sati Pharma Limited — 360° Intelligence Report
Generated from MCA filings & public recordsSati Pharma Limited is assessed as Moderate with a Trust Score of 52/100. Sati Pharma Limited is a public limited indian non-government company incorporated in 2003, operating in the Home Appliances sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and an unassessed financial risk profile.
Report generated on 17 Oct 2026 from the latest processed filings. Sati Pharma Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
No processed financialsCredit & Compliance Intelligence
Why the scores are what they are- Financial statements needed for a credit view.
Charges position: 2 open (3.75 cr) · 1 satisfied (-).
| Lender | Charges | Amount |
|---|---|---|
| Indian Overseas Bank | 2 | 48.0 cr |
| Central Bank Of India | 1 | 48.0 cr |
- Company status is "Strike Off" - not Active.
- No balance-sheet filing date on record.
- Litigation present in 1 court forum(s).
Director Intelligence
Stability score: 25/100Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth N/A · Distress 65Stakeholder Verdicts
Vendor · Banker · Investor- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- No financials on record - ask for audited statements.
- No filed financials - rely on banking statements and GST data.
- 2 open charge(s) of 3.75 cr already registered.
- Compliance gaps should be priced into terms.
- No clear growth signals in the filed years.
- Request management accounts - public filings insufficient.
- Management churn warrants questions.
MCA Filings & Events Timeline
Latest 5 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Alchemy Urbanventures Private Limited | U51101MH2008PTC185461 | Mumbai, Maharashtra |
| Full Frame Media Private Limited | U92120MH2009PTC197613 | Mumbai, Maharashtra |
| SHAH DILIPKUMAR LALCHAND TEXTILES LLP | AAW-6335 | Mumbai, Maharashtra |
| AMBAVAT JAIN & ASSOCIATES LLP | AAA-7120 | Mumbai, Maharashtra |
| Kotwala Enterprise Private Limited | U45200MH1989PTC051452 | Mumbai, Maharashtra |
| Blue Vision Cable Network Private Limited | U74999MH2016PTC288846 | Mumbai, Maharashtra |
| ADAN TRADERS LLP | AAD-8043 | Mumbai, Maharashtra |
| Jaipur Enclave Private Limited | U15433MH2005PTC301151 | Mumbai, Maharashtra |
| Goodwill Multitrade Private Limited | U51109MH2009PTC194311 | Mumbai, Maharashtra |
| Sumatinath Import And Export Private Limited | U74999MH2016PTC282933 | Mumbai, Maharashtra |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Sati Pharma Limited before audits and certifications: compliance score 38/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Sati Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Enhanced diligence advised. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Sati Pharma Limited - screening before a deeper diligence.
Vendor verdict: Review suggested. Trust score 52/100, distress signals and MSME payment-delay disclosures - know whether Sati Pharma Limited pays its suppliers before you extend credit terms.
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Sati Pharma Limited - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Sati Pharma Limited an active company?
Sati Pharma Limited has MCA status “Strike Off” with a compliance score of 38/100 (Caution Indicated).
Is Sati Pharma Limited financially healthy?
Processed financial statements are not yet available for Sati Pharma Limited, so its financial health is unassessed.
Should I do business with Sati Pharma Limited?
Its overall Trust Score is 52/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Sati Pharma Limited?
See the directors and ownership sections above for board and shareholding detail.
Does Sati Pharma Limited have loans or charges against its assets?
2 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.
Is Sati Pharma Limited up to date with its ROC filings?
No balance-sheet filing date on record. Overall compliance score: 38/100 (Caution Indicated).
Is it risky to lend to Sati Pharma Limited?
Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.